Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

315
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
315
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

422
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
422
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

2.4K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.4K
Pneumonia IV: Management01:28

Pneumonia IV: Management

437
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
437
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

473
The pathophysiology of pneumonia involves the following steps:
473
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

12.2K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
12.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of COVID-19-related data drift on machine-learning prognostic models predicting 30-day opioid-related emergency department visits, hospitalisation or mortality: a population-level administrative data study in Alberta, Canada.

BMJ open·2026
Same author

Correction: Influence of the COVID-19 pandemic on chronic disease management among indigenous people in Canada.

Frontiers in public health·2026
Same author

'It's not just diabetes': implementation enablers and barriers of an indigenous-focused virtual diabetes care clinic using the Consolidated Framework for Implementation Research (CFIR) - a qualitative assessment.

BMJ open·2026
Same author

Becoming Invisible: How Mental Health Systems Erode Selfhood in Young Adults With Mental Health-Related Disabilities.

Qualitative health research·2026
Same author

Mental Health-Related Disabilities, Healthcare Utilization, and Access in Young Adults with Anxiety and Depression: A Scoping Review.

Administration and policy in mental health·2026
Same author

Influence of the COVID-19 pandemic on chronic disease management among indigenous people in Canada.

Frontiers in public health·2026
Same journal

Detection of and Early Genomic Insights into Chikungunya Virus, Bolivia, 2025.

Emerging infectious diseases·2026
Same journal

Household Transmission of Enterovirus D68, Washington and Oregon, United States, 2022-2024.

Emerging infectious diseases·2026
Same journal

New World Ocular Dirofilariasis Caused by Dirofilaria repens Infection, United States.

Emerging infectious diseases·2026
Same journal

Angiostrongylus cantonensis Rat Lungworm Detected in Rats, Madagascar, 2022-2023.

Emerging infectious diseases·2026
Same journal

Human Pulmonary Dirofilariasis,
North Queensland, Australia, 2023<sup>1</sup>.

Emerging infectious diseases·2026
Same journal

Trends in Congenital Syphilis Cases by Maternal Country of Birth, Spain, 2016-2024.

Emerging infectious diseases·2026
See all related articles

Related Experiment Video

Updated: Sep 3, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.2K

Invasive Pneumococcal Disease and Long-Term Mortality Rates in Adults, Alberta, Canada.

Kristen A Versluys, Dean T Eurich, Thomas J Marrie

    Emerging Infectious Diseases
    |July 25, 2022
    PubMed
    Summary
    This summary is machine-generated.

    Invasive pneumococcal disease (IPD) is linked to higher short, intermediate, and long-term mortality. This study highlights the persistent risk, emphasizing the need for ongoing patient care post-infection.

    Keywords:
    AlbertaCanadabacteriainvasive pneumococcal diseaselong-term mortality ratespneumococciproportional hazards modelrespiratory infections

    More Related Videos

    A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
    12:21

    A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

    Published on: September 28, 2022

    2.6K
    Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
    09:12

    Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

    Published on: January 17, 2014

    12.6K

    Related Experiment Videos

    Last Updated: Sep 3, 2025

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
    11:32

    Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

    Published on: February 23, 2014

    15.2K
    A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
    12:21

    A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

    Published on: September 28, 2022

    2.6K
    Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae
    09:12

    Characterization of Inflammatory Responses During Intranasal Colonization with Streptococcus pneumoniae

    Published on: January 17, 2014

    12.6K

    Area of Science:

    • * Infectious Diseases
    • * Public Health
    • * Epidemiology

    Background:

    • * Short-term mortality following invasive pneumococcal disease (IPD) is well-documented.
    • * The long-term mortality impact of IPD remains largely uncharacterized.
    • * Understanding long-term outcomes is crucial for comprehensive patient management.

    Purpose of the Study:

    • * To investigate the association between invasive pneumococcal disease and long-term all-cause mortality.
    • * To quantify the excess mortality risk in IPD survivors over different time intervals.
    • * To identify the sustained impact of IPD on patient survival.

    Main Methods:

    • * Retrospective cohort study utilizing linked clinical and administrative data from Alberta, Canada.
    • * Inclusion of 4,522 patients with a first IPD event.
    • * Cox proportional hazards modeling to assess time to all-cause mortality, with a median follow-up of 3.2 years.

    Main Results:

    • * Consistently higher all-cause mortality rates observed in IPD cases compared to controls at 30 days (aHR 3.75), 30-90 days (aHR 1.56), and beyond 90 days (aHR 1.43).
    • * The increased mortality risk persisted across various age groups, sexes, and individuals with concurrent health conditions.
    • * Significant excess mortality was evident in the short, intermediate, and long-term periods post-IPD.

    Conclusions:

    • * Invasive pneumococcal disease significantly elevates the risk of both short-term and long-term mortality.
    • * The findings underscore the importance of considering long-term health consequences beyond the acute phase of IPD.
    • * Clinical strategies should incorporate post-discharge care plans to mitigate the enduring effects of IPD on survival.